Learn how these therapies work beyond weight management and what the newest evidence means for patients and providers
Furthermore, prospective cohort studies have demonstrated that GLP-1RA treatment leads to improvements in forced expiratory volume in one second (FEV 1 ), forced vital capacity (FVC), and maximal expiratory flow (MEF) compared to baseline, insulin-treated, and control cohorts [78]
Cell Mol Gastroenterol Hepatol
Peptide therapy is most relevant for patients managing TMJ disorder, myofascial pain syndrome, periodontal disease, chronic oral inflammation, or those seeking to optimize healing around dental implants or surgical procedures
Gastrointestinal protection BPC 157 was originally isolated from gastric juice and has a protective effect on the gastrointestinal tract